Barbara Koumaras

Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials

Elizabeth Berry‐Kravis, Vincent des Portes, Randi J. Hagerman et al. · Science Translational Medicine · 2016 · 260 citations

Effects of rivastigmine on cognitive function in patients with traumatic brain injury

Jonathan Silver, Barbara Koumaras, M. Chen et al. · Neurology · 2006 · 124 citations

Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study

Donald B. Bailey, Elizabeth Berry‐Kravis, Anne Wheeler et al. · Journal of Neurodevelopmental Disorders · 2015 · 99 citations · Full text

Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study

Jeffrey L. Cummings, Barbara Koumaras, Michael Chen et al. · ˜The œAmerican journal of geriatric pharmacotherapy · 2005 · 94 citations

Probable Alzheimer, Neuropsychology, Alzheimer's Disease +13

Analysis of Outcome in Retrieved Dropout Patients in a Rivastigmine vs Placebo, 26-Week, Alzheimer Disease Trial

Martin R. Farlow, Steven G. Potkin, Barbara Koumaras et al. · Archives of Neurology · 2003 · 73 citations